February 17th 2023
The launch of Amgen's adalimumab biosimilar Amjevita was just the start of a wave of biosimilars to treat autoimmune diseases.
January 30th 2023
Greater Satisfaction Reported With Extended-Wear Insulin Infusion Set for Type 1 Diabetes
June 25th 2021A study presented during a poster session at the American Diabetes Association Virtual 81st Scientific Sessions evaluated performance, safety, and satisfaction of an extended-wear insulin infusion set in patients with type 1 diabetes.
High Adherence, Low Adverse Events Reported Across Different Oral Disease-Modifying Therapies
April 21st 2021Research presented at Academy of Managed Care Pharmacy’s 2021 virtual conference evaluated tolerance and adherence to oral disease-modifying therapies for relapsing-remitting multiple sclerosis.